Provided by Tiger Fintech (Singapore) Pte. Ltd.

Coherus BioSciences

0.7818
-0.0349-4.27%
Post-market: 0.7712-0.0106-1.36%19:32 EDT
Volume:1.88M
Turnover:1.48M
Market Cap:90.61M
PE:3.14
High:0.8167
Open:0.7900
Low:0.7501
Close:0.8167
Loading ...

Coherus BioSciences to Repurchase $170 Million Convertible Notes

MT Newswires Live
·
01 Apr

Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes

THOMSON REUTERS
·
01 Apr

Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes

GlobeNewswire
·
01 Apr

Coherus BioSciences Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
14 Mar

Coherus BioSciences’ Earnings Call: Growth and Challenges

TIPRANKS
·
12 Mar

Q4 2024 Coherus BioSciences Inc Earnings Call

Thomson Reuters StreetEvents
·
12 Mar

Coherus BioSciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

Coherus BioSciences Inc (CHRS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
11 Mar

Coherus BioSciences Reports 2024 Financial Growth

TIPRANKS
·
11 Mar

Coherus BioSciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Mar

Coherus BioSciences Q4 Net Loss Narrows, Revenue Declines

MT Newswires Live
·
11 Mar

Coherus BioSciences: Q4 Earnings Snapshot

Associated Press Finance
·
11 Mar

Coherus BioSciences Q4 2024 Adj. EPS $(0.28) Misses $(0.13) Estimate, Sales $54.144M Beat $47.270M Estimate

Benzinga
·
11 Mar

BRIEF-Coherus BioSciences Q4 Net Income USD -50.696 Million

Reuters
·
11 Mar

Coherus BioSciences Inc - Post Divestiture Cash Expected at $250 Million, Headcount Reduced by 30%

THOMSON REUTERS
·
11 Mar

Coherus BioSciences Inc -Approximately 50 Employees Associated With Udenyca Are Expected to Transfer to Accord Biopharma

THOMSON REUTERS
·
11 Mar

Coherus BioSciences Inc -Qtrly Shr Loss $0.44

THOMSON REUTERS
·
11 Mar

Coherus BioSciences Q4 Net Income USD -50.696 Million

THOMSON REUTERS
·
11 Mar

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
11 Mar

Coherus BioSciences Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
08 Mar